Key takeaways from the ASP Symposium at the WFHSS in Geneva, 20 Nov 2021

It has been a pleasure having all 200+ attendees at the ASP Symposium on Nov 20th, 2021 at the WFHSS in Geneva. The topic of the symposium was:

“The importance of Low Temperature Sterilization Validation & Compliance”

Here some key takeaways from our three renowned speakers:

Patrick Turner, Beaumont Hospital, Ireland:

“Comprehensive research on MD compatibility with its vital before medical devices are reprocessed for the first time. Monitoring over time is key to producing a quality product. Review the data and propose improvements were applicable.”

Ben Fryer, ASP R&D:

“A Biological Indicator BI) is used only demonstrate necessary conditions were met to achieve sterilization. A Process Challenge Device (PCD) is better than BI because assess process performance by providing a challenge equal or greater than most difficult items routinely processed”

Wouter Meert, UZ Leuven, Belgium:

“Low temp sterilization by Hydrogen Peroxide became a standard in the reprocessing of Medical Devices. Take the opportunity to create a qualitative process in your CSSD based on the ISO 13485”.

Want to know more of what was discussed during the symposium?

DOWNLOAD THE KEY TAKEAWAY FACTSHEET

Key takeaways from the ASP Symposium at the WFHSS in Geneva, 20 Nov 2021

Disclaimer